ReviewBiochemical pharmacology2012

Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management.

Vaqar Mustafa Adhami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.